Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Study of Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in Early Stage, HER-2 Positive Breast Cancer

NCT00148668 is registered in ClinicalTrials.gov with Eric Winer, MD as lead sponsor.

NCT NCT00148668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00148668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Study of Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in Early Stage, HER-2 Positive Breast Cancer
Lead sponsor
Eric Winer, MD
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2003
Completion date
August 31, 2011
Enrollment
81 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer